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Background: We previously investigated the current status of breast cytology cancer screening at seven institutes
in our area of southern Fukuoka Prefecture, and found some differences in diagnostic accuracy among the
institutions. In the present study, we evaluated the cases involved and noted possible reasons for their original
cytological classification as inadequate, indeterminate, false-negative and false-positive according to histological
type.
Methods: We evaluated the histological findings in 5693 individuals who underwent cytological examination for
breast cancer (including inadequate, indeterminate, false-negative and false-positive cases), to determine the most
common histological types and/or features in these settings and the usefulness/limitations of cytological
examination for the diagnosis of breast cancer.
Results: Among 1152 cytologically inadequate cases, histology revealed that 75/173 (43.6%) cases were benign,
including mastopathy (fibrocystic disease) in 38.6%, fibroadenoma in 24.0% and papilloma in 5.3%. Ninety-five of
173 (54.9%) cases were histologically malignant, with scirrhous growing type, invasive ductal carcinoma (SIDC) being
significantly more frequent (49.5%) than papillotubular growing type (Papi-tub) (P< 0.0001), solid-tubular growing
type (P= 0.0001) and ductal carcinoma in situ (DCIS) (P= 0.0001). Among 458 indeterminate cases, 54/139 (38.8%)
were histologically benign (mastopathy, 30.0%; fibroadenoma, 27.8%; papilloma, 26.0%) and 73/139 (52.5%) were
malignant, with SIDC being the most frequent malignant tumor (37.0%). Among 52 false-negative cases, SIDC was
significantly more frequent (42.3%) than DCIS (P= 0.0049) and Papi-tub (P= 0.001). There were three false-positive
cases, with one each of fibroadenoma, epidermal cyst and papilloma.
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Conclusions: The inadequate, indeterminate, false-negative and false-positive cases showed similar histological
types, notably SIDC for malignant tumors, and mastopathy, fibroadenoma and papilloma for benign cases. We need
to pay particular attention to the collection and assessment of aspirates for these histological types of breast
disease. In particular, several inadequate, indeterminate and false-negative cases with samples collected by
aspiration were diagnosed as SIDC. These findings should encourage the use of needle biopsy rather than
aspiration when this histological type is identified on imaging. Namely, good communication between clinicians
and pathological staff, and triple assessment (i.e., clinical, pathological and radiological assessment), are important
for accurate diagnosis of aspiration samples.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/7349809170055423
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The choice of sampling technique for breast disease has
been discussed and might depend on the inadequate
diagnostic rates for that methodology [1-3]. For example,
the inadequate and indeterminate rates for fine needle
aspiration biopsy (FNAB) and needle biopsy should be
<10%, as recommended in the Japanese guidelines [4].
However, some Japanese physicians believe that needle
biopsy can better avoid inadequate and/or indeterminate
results than can FNAB. Nevertheless, whether this is true
or not, some of them perform needle biopsy instead of
FNAB. On the other hand, increased breast cancer
screening is expected. Therefore, low-cost and simple
methods are needed for routine procedures, and cyto-
logical examination may fulfill these criteria. As the first-
line pathological investigation (i.e., symptomatic lesions,
confirming of benign lesions), FNAB could be appropri-
ate for breast cancer screening, with the exception of
microcalcifications [1].
In such circumstances, we recently reported the accur-
acy of cytological diagnosis compared with histological
diagnosis of breast disease in institutes in our area of
southern Fukuoka Prefecture, Japan [5]. We found that
the accuracy of cytological diagnosis at these institutes was
equivalent to that recommended for diagnostic accuracy
in Japanese [4] and UK [6,7] guidelines. It was also equiva-
lent to data reported in other countries [8,9]. However,
overall performance differed among the institutes, and
was related to the characteristics of these institutes (e.g.,
the number of cases, number of staff, and specialism).
Furthermore, the number of false-positive and false-
negative cases should be as low as possible. To confirm
the validity of cytological examinations for breast cancer,
managing the accuracy of the examinations is essential.
Our earlier study also focused on the differences in the
performance of FNAB among institutions.
Therefore, in the present study, we evaluated the inad-
equate, indeterminate, false-negative and false-positive
cases to determine the most common histological typesand/or features in these settings, and to demonstrate the
usefulness and/or limitations of cytological examination
for the diagnosis of breast cancer from the viewpoint of
histological types.
Patients and methods
We conducted a 1-year survey of seven institutes that
dealt with many patients, along with a multiple-year sur-
vey of institutes with ≤ 100 cases per year. We analyzed
data from 2009 and earlier, as previously described [5].
Classification of cytology and histological samples
In accordance with the General Rules for Clinical and
Pathological Recording of Breast Cancer prepared by the
Japanese Breast Cancer Society in 2005, individual sam-
ples were initially rated as “inadequate” or “adequate”.
Samples rated as the latter were graded on a four-
category scale: “normal/benign”, “indeterminate” (diffi-
cult to distinguish between “benign” and “malignant”),
“malignancy suspected”, and “malignant” [4].
Invasive ductal carcinoma (IDC) –not otherwise speci-
fied (NOS) based on the WHO classification [10] was
classified into three subgroups based on Japanese Breast
Cancer Society guidelines, as follows: (i) papillotubular
growing type (Papi-tub), which is characterized by the
projection of papillae into spaces, and includes cribri-
form and comedo patterns [4]; (ii) solid tubular growing
type (Solid-tub), which is a solid cluster of cancer cells
with expansive growths that form relatively sharp
borders [4]; and (iii) IDC growing in a scirrhous manner
(scirrhous carcinoma; SIDC), which is characterized by
cancer nests or cells accompanied by marked fibrosis [4].
Representative histopathological specimens of these sub-
types of IDC-NOS are shown in Figures 1, 2 and 3.
Variables assessed
Data were collected for 5693 cases. The diagnosis was
established histologically in 1250 (22.0%) of these cases,
which formed the basis for determining the diagnostic
Figure 1 Representative histopathological specimens of the
three subtypes of invasive ductal carcinoma–not otherwise
specified. Papillotubular growing type (Papi-tub) is characterized by
the projection of papillae into spaces, and includes cribriform and
comedo patterns [4].
Figure 3 Representative histopathological specimens of the
three subtypes of invasive ductal carcinoma–not otherwise
specified. Invasive ductal carcinoma growing in a scirrhous manner
(scirrhous carcinoma; SIDC) is characterized by cancer nests or cells
accompanied by marked fibrosis [4].
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terminate cases based on cytological examinations were
confirmed by histological findings, and any cases with
discrepancies between the cytological and histological
diagnosis (i.e., false-negative and false-positive cases)
were analyzed. The assessments reported in our previous
study are shown (with permission) in Table 1, includingFigure 2 Representative histopathological specimens of the
three subtypes of invasive ductal carcinoma–not otherwise
specified. Solid tubular growing type (Solid-tub) consists of a solid
cluster of cancer cells with expansive growths that form relatively
sharp borders [4].the number of cases in the following categories: inad-
equate cases, C1 +G1 (benign) and E1 + J1 (malignant);
indeterminate cases, C3 +G3 (benign) and E3 + J3 (ma-
lignant); false-negative cases, E2 + J2; and false positive
cases, C5 +G5. False-negative cases and false-positive
cases were reviewed by two investigators (R.Y. and T.Y.)
who performed microscopic analyses.
Statistical analyses
Differences among histological subtypes in inadequate,
indeterminate, and false-negative cases and differences
between inadequate and indeterminate cases in terms of
histological types were assessed using independent-
samples χ2 tests for groups with n > 5, and Fisher’s exact
p test for groups with n ≤ 5.
Results
Analysis of inadequate cases based on cytological
diagnosis
Of 5693 cases, 1152 were inadequate (A1) based on cyto-
logical examinations. Of these, 173 (15.0%) were con-
firmed histologically. We first analyzed cases where the
sample for cytological examination was classified as inad-
equate but the final histological diagnosis was benign.
Seventy-five of 173 (43.6%) cytologically inadequate cases
were classified as C1 +G1 (benign) based on histology.
Among these cases, the most frequent histological type
was mastopathy (fibrocystic disease) (29/75 cases,
38.6%), followed by fibroadenoma (18/75, 24.0%) and
intraductal papilloma (4/75, 5.3%). There were no signifi-
cant differences in the frequencies of these histological
types. The other cases were rated as having benign dis-
ease or as benign (24/75, 32.0%) (Figure 4). Overall,
Table 1 Classification of cases and method used for diagnosis (used with permission from [5])
Histology (B3)
Cytological category (n) By operation (B1) By needle biopsy (B2)





Inadequate A1 C1 D1 E1 F1 G1 H1 I1 J1
(1152) (12) (0) (82) (0) (63) (3) (0) (13)
Normal or benign A2 C2 D2 E2 F2 G2 H2 I2 J2
(2914) (85) (32) (40) (3) (99) (2) (0) (12)
Indeterminate A3 C3 D3 E3 F3 G3 H3 I3 J3
(458) (27) (5) (63) (3) (27) (4) (0) (10)
Malignancy suspected A4 C4 D4 E4 F4 G4 H4 I4 J4
(272) (3) (0) (65) (0) (11) (0) (0) (27)
Malignancy A5 C5 D5 E5 F5 G5 H5 I5 J5
(897) (3) (0) (521) (0) (0) (0) (0) (35)
Total A6 C6 D6 E6 F6 G6 H6 I6 J6
(5693) (130) (37) (771) (6) (200) (9) (0) (97)
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choic area on ultrasound (US) of≤ 1 cm.
Next, we assessed cytologically inadequate cases with a
final histological diagnosis of malignant. Overall, 95/173
(54.9%) cytologically inadequate cases were classified as
E1 + J1 (malignant). Of these cases, > 70% had IDC-
NOS. Among these, the most frequent histological sub-
type was SIDC (47/95, 49.5%), followed by Papi-tub (17/
95, 17.9%), Solid-tub (15/95, 15.8%) and ductal carcin-
oma in situ (DCIS) (6/95, 6.3%). The other 10 cases had
other malignant histological types, including special
types. SIDC was significantly more frequent than Papi-Figure 4 Final histological diagnosis of benign cases classified as inad
frequent histological type was mastopathy (fibrocystic disease) (29/75 cases
papilloma (4/75, 5.3%). There were no significant differences in the frequen
histological types included mastopathy (16/54, 30.0%), fibroadenoma (15/54
seen in three cases (5.6%). There were no significant differences in the freq
frequent in indeterminate cases than in inadequate cases (26% vs 5%; *P =
phyllodes tumor.tub (P < 0.0001), Solid-tub (P= 0.0001) and DCIS
(P= 0.0001). There were no significant differences in the
frequencies of the other subtypes (Figure 5). Overall,
21.1% (20/95) of these cytologically inadequate cases had
a tumor size or hypoechoic area on US of≤ 1 cm.
Analysis of indeterminate cases based on cytological
diagnosis
There were 458 indeterminate cases (A3) based on cyto-
logical examinations. Of these, 139 (30.3%) were confirmed
histologically. A total of 54/139 (38.8%) histologically inde-
terminate cases were classified as C3+G3 (benign). Ofequate or indeterminate. Among inadequate cases, the most
, 38.6%), followed by fibroadenoma (18/75, 24.0%) and intraductal
cies of these histological types. Among indeterminate cases, the
, 27.8%) and intraductal papilloma (14/54, 26.0%). Phyllodes tumor was
uencies of these histological types. Papilloma was significantly more









Figure 5 Final histological diagnosis of malignant cases
classified as inadequate or indeterminate. Among inadequate
cases, the most frequent histological subtype was SIDC (47/95,
49.5%), followed by Papi-tub (17/95, 17.9%), Solid-tub (15/95, 15.8%)
and DCIS (6/95, 6.3%). SIDC was significantly more frequent than
Papi-tub (**P < 0.0001), Solid-tub (***P = 0.0001) and DCIS (***P =
0.0001). Among indeterminate cases, the most common histological
types were SIDC (27/73, 37.0%), Papi-tub (26/73, 35.6%), DCIS (7/73,
9.6%) and Solid-tub (7/73, 9.6%). There were no significant
differences in the frequencies of these histological types. Papi-tub
was significantly more frequent in indeterminate cases than in
inadequate cases (36% vs 18%, P = 0.0151*). Dark gray, inadequate;
light gray; indeterminate. SIDC, scirrhous growing type, invasive
ductal carcinoma; Solid-tub, solid-tubular growing type, invasive
ductal carcinoma; Papi-tub, papillotubular growing type, invasive
ductal carcinoma; DCIS, ductal carcinoma in situ.
*
**
Yamaguchi et al. Diagnostic Pathology 2012, 7:53 Page 5 of 8
http://www.diagnosticpathology.org/content/7/1/53these, the histological types included mastopathy (16/54,
30.0%), fibroadenoma (15/54, 27.8%) and intraductal papil-
loma (14/54, 26.0%). Phyllodes tumor was seen in three
cases (5.6%). The other six cases represented other benign
histological lesions. There were no significant differences in
the frequencies of these histological types (Figure 4). Among
these cases, 22.0% (12/54) had a tumor size or hypoechoic
area on US of≤1 cm.
Seventy-three of 139 (52.5%) cases were classified as
E3+ J3 (malignant). The most common histological types
were SIDC (27/73, 37.0%), Papi-tub (26/73, 35.6%), DCIS
(7/73, 9.6%) and Solid-tub (7/73, 9.6%). The other six cases
were of other malignant histological types. There were no
significant differences in the frequencies of these histo-
logical types (Figure 5). In 26.0% (19/73) of the cases, the
tumor size or hypoechoic area on US was≤ 1 cm.n=22 n=11 n=8 n=4 n=7
Figure 6 Final histological diagnosis of false-negative cases
based on cytological examination. SIDC was significantly more
frequent than DCIS (*P = 0.0049) and Papi-tub (**P = 0.001). SIDC,
scirrhous growing type, invasive ductal carcinoma; Solid-tub, solid-
tubular growing type, invasive ductal carcinoma; Papi-tub,
papillotubular growing type, invasive ductal carcinoma; DCIS, ductal
carcinoma in situ.Comparison of histological types between inadequate and
indeterminate cases
Regarding benign diseases, papilloma was significantly
more common in indeterminate cases than in inadequate
cases (26% vs 5%, P= 0.0014). By contrast, there were no
significant differences in the frequencies of mastopathy
or fibroadenoma between inadequate and indeterminate
cases (Figure 4). For malignant diseases, Papi-tub wassignificantly more frequent in the indeterminate cases
than in the inadequate cases (36% vs 18%, P= 0.0151).
The frequencies of SIDC, Solid-tub and DCIS were not
significantly different between the inadequate and inde-
terminate cases (Figure 5).Analyses of histological type for false-negative and false-
positive cases
As shown in Table 1, there were 52 false-negative cases
(6.7%), corresponding to E2 + J2. Histologically, these 52
cases consisted of 22 SIDC cases (42.3%), 11 Solid-tub
cases (21.2%), eight DCIS cases (15.4%), four Papi-tub
cases (7.7%) and seven other cases of special types
(13.5%) (i.e., mucinous carcinoma, invasive micropapillary
carcinoma). SIDC was significantly more frequent than
DCIS (P=0.0049) and Papi-tub (P=0.001). There were no
significant differences in the frequencies of the other sub-
types (Figure 6).
As shown in Table 1, there were three false-positive cases
(0.10%) corresponding to C5+G5, with the final histological
types being fibroadenoma, intraductal papilloma and
epidermal cyst. The fibroadenoma was incorrectly rated as
positive because there were marked hyperplastic changes of
the ductal epithelial cells, which was judged to be malignant
atypism. The intraductal papilloma was incorrectly rated as
positive because the examiner had limited experience and
attached to much importance to the large cell volume. The
epidermal cyst was incorrectly rated as positive
because atypical squamous epithelial cells with atypical
signs (i.e., necrosis accompanied by inflammation) were
noted.
Figure 7 Representative cytological findings of invasive ductal
carcinoma, scirrhous growing type (SIDC). The cells form small
clusters with little atypia on cytological specimens, which hinders
attempts to differentiate between benign and malignant cases. This
often results in the classification of these cases as indeterminate
and/or false-negative. Cases of SIDC are sometimes classified as
inadequate when too few cells are collected for evaluation,
especially for tumors rich in fibrous components, as these are
difficult to sample [12].
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In this study, we analyzed cytologically inadequate and
indeterminate cases, as well as false-negative and false-
positive cases, by evaluating the histological features of
these cases.
In cases where the sample was rated as inadequate,
SIDC was the most common histological type of malig-
nant tumor, while mastopathy was the most frequent be-
nign disease. It was reported that SIDC cases are often
classified as inadequate [11] because SIDC usually con-
sists of abundant fibrous elements, which hinders sample
collection [11]. Because tumors ≤ 1 cm in size are rela-
tively infrequent among cases with inadequate samples,
it seems likely that the histological type or property (i.e.,
hard tumor or difficult to collect) is cited more fre-
quently than is tumor size as the reason for rating the
sample as inadequate. In 1998, it was reported that
tumors of≤ 1 cm tend to be insufficient [12]. However,
we consider that techniques for sample collection have
improved since that study.
Among the indeterminate cases with benign diseases,
the frequencies of mastopathy, fibroadenoma and papil-
loma were similar. Among indeterminate cases with
malignant diseases, the frequency of Papi-tub was high,
nearing that of SIDC. These findings suggest that differen-
tiating between epithelial hyperplastic changes and atyp-
ical cancer cells may be difficult. In addition, there are
two types of Papi-tub. The first is the papillotubular nodu-
lar type, including cribriform carcinoma, and the second
mainly consists of intraductal carcinoma components
associated with invasive lesions. Both types are generally
well differentiated with little cell atypia. The size of
tumors in cases rated as indeterminate was not always
small, similar to that for inadequate samples. The cases
were mainly rated as indeterminate because of tissue fea-
tures rather than tumor size.
The present study revealed that cases with SIDC or
mastopathy were likely to be rated as indeterminate or
inadequate samples. Cases of SIDC are sometimes classi-
fied as inadequate when too few cells are collected for
evaluation, especially for tumors rich in fibrous compo-
nents, as these are difficult to sample [11]. When sam-
ples can be extracted, the cells commonly form small
clusters with little atypia on cytological specimens, which
hinders attempts to distinguish between benign and ma-
lignant cases. This often results in the rating of these
cases as indeterminate (representative cytological speci-
mens of SIDC as shown in Figure 7). Meanwhile, it may
be difficult to obtain samples from cases of mastopathy
(fibrocystic disease) and assess hyperplastic changes of the
epithelial cells (i.e., ductal hyperplasia). Moreover, some
histological types classified as indeterminate differed from
those classified as inadequate samples. For example, among
benign diseases, papilloma was more frequently classifiedas indeterminate rather than inadequate. Among malignant
diseases, Papi-tub was more frequently classified as indeter-
minate rather than inadequate.
We found that the most frequent histological type of
tumor among the false-negative cases was SIDC. Indeed,
cases of SIDC are often reported as false-negatives [11],
a finding confirmed by our data. SIDC usually shows
with thick fibrosis and, when samples can be extracted,
the cells commonly form small clusters with little atypia;
this is also why cases with SIDC are often rated as inad-
equate and indeterminate. Moreover, the atypical cells
were relatively small and were similar in appearance to
benign or hyperplastic cells.
False-positive cases included cases with papilloma or
fibroadenoma, which involve marked hyperplasia of epi-
thelial cells [12,13]. Therefore, particular care is needed
during cytology of cases in which a papillary structure or
a cribriform pattern is seen. Fibroadenomas are divided
into subtypes based on epithelial morphology. For
example, the mastopathic type is often mistaken as a
malignant tumor based on clinical signs, and the
presence of epithelial hyperplasia within the tumor at the
time of cytology and needle biopsy [14-16]. In the
present study, one fibroadenoma was incorrectly
classified as malignant because epithelial hyperplasia
within the tumor was incorrectly identified. In this case,
however, the fibroadenoma was of a type undergoing
marked stromal myxomatous changes (i.e., myxomatous
fibroadenoma). We previously reported that the intersti-
tial components of fibroadenoma should receive
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type of fibroadenoma can be mistaken for a malignant
tumor based on US findings, particularly marked growth
of the stroma. Therefore, evaluation of the surrounding
stroma (e.g., by checking for metachromasia on Giemsa
staining) in addition to epithelial cells will help avoid mis-
diagnosis [17,18].
With the increasing implementation of screening pro-
grams in Japan, cytological examination of breast tissue
is of increasing importance. Therefore, improving the ac-
curacy of FNAB is an important issue, even though we
showed that the accuracy of FNAB is as high as that
recommended under the relevant clinical guidelines [5].
We believe that there is room for improvement. For
example, it is important to acknowledge that certain
histological types, such as SIDC for malignant breast dis-
eases, make tissue aspiration and diagnosis difficult. In-
deed, SIDC tended to be diagnosed in cases classified as
inadequate, indeterminate and false-negative using aspi-
rated samples in the present study. SIDC was reported
to be easy to recognize using appropriate imaging mo-
dalities (i.e., mammography and/or US) [11]. Therefore,
the present findings should encourage the use of needle
biopsy rather than aspiration when this histological type
is suspected based on imaging. Furthermore, triple as-
sessment (i.e., clinical, pathological and radiological as-
sessment) should be considered in some cases [5,19]. It
is also important that staff receive appropriate patho-
logical and clinical training, and that there is good com-
munication between clinicians and pathological staff [5].
Finally, because there are institutional differences, we
recommend that a management system is established to
facilitate accurate cytological examination and diagnosis,
as we have already reported [5].Conclusions
The inadequate, indeterminate, false-negative and false-
positive cases showed similar histological types, notably
SIDC for malignant tumors, and mastopathy, fibroaden-
oma and papilloma for benign cases. We need to pay
particular attention to the collection and assessment of
aspirates. Diagnosis should be reached while considering
possible errors in diagnosis for these histological types of
breast disease. In particular, several inadequate, indeter-
minate and false-negative cases with samples collected
by aspiration were diagnosed as SIDC. These findings
should encourage the use of needle biopsy rather than
aspiration when this histological type is identified on
imaging.Abbreviations
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